Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JCR Pharmaceuticals Co's dividends per share for the
three
months ended in Mar. 2026 was $0.13. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.19. Its Dividend Payout Ratio for the
three
months ended in Mar. 2026 was 21.00. As of today, JCR Pharmaceuticals Co's Dividend Yield % is 3.76%.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JCR Pharmaceuticals Co Ltd is 2.99, which seems too high.
During the past 5 years, the average Dividends Per Share Growth Rate was -1.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 18.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of JCR Pharmaceuticals Co was 51.30% per year. The lowest was -3.90% per year. And the median was 15.00% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
During the past 13 years, the highest Dividend Payout Ratio of JCR Pharmaceuticals Co was 4.50. The lowest was 0.16. And the median was 0.39.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JCR Pharmaceuticals Co Ltd is 2.99, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
JCR Pharmaceuticals Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 10.000000
2026-03-31
2026-03-31
2026-06-24
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 10.000000
2026-03-30
2026-03-31
0000-00-00
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 10.000000
2025-09-29
2025-09-30
2025-12-05
Cash Dividend
semi-annually
JPY:USD 0.006758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
JCR Pharmaceuticals Co's Dividend Yield (%) for Today is calculated as
Current Share Price is $3.31.
JCR Pharmaceuticals Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.1933.
During the past 13 years, the highest Dividend Yield of JCR Pharmaceuticals Co was 4.75%. The lowest was 0.25%. And the median was 0.77%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCR Pharmaceuticals Co Dividends per Share Related Terms
JCR Pharmaceuticals Co Dividends per Share Historical Data
* Premium members only.
The historical data trend for JCR Pharmaceuticals Co's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCRRF vs LLY, JNJ, ABBV: Dividends per Share Comparison
For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JCR Pharmaceuticals Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where JCR Pharmaceuticals Co's Dividend Yield % falls into.
JCR Pharmaceuticals Co (JCRRF) has a Dividends per Share of $0.19 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Dividends per Share too high?
JCR Pharmaceuticals Co's current Dividends per Share is $0.19. Overall, JCR Pharmaceuticals Co has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Dividends per Share compare to LLY and JNJ?
JCR Pharmaceuticals Co's Dividends per Share of $0.19 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Dividends per Share is $0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.13, compared to a current price of $3.31 — trading 35.5% below its estimated fair value. The current Dividends per Share is $0.19. JCR Pharmaceuticals Co's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current Dividends per Share is $0.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued.
The current stock price of $3.31 is trading 35.5% below its estimated GF Value™ of $5.13.
GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.
Key valuation signals for JCRRF:
Dividends per Share: $0.19
GF Value™: $5.13 vs. price of $3.31 (35.5% below fair value)
No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
54GF Score
Get the complete analysis for JCRRF
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JCRRF has been successfully added to your 
